FTSE All-Share
4.801,14
PKT
-22,41
PKT
-0,46
%
Werbung
Analysen zu FTSE All-Share-Werten
Datum | Rating | Analyst | |
---|---|---|---|
02.05.25 | London Stock Exchange (LSE) Buy | Deutsche Bank AG | |
02.05.25 | London Stock Exchange (LSE) Buy | UBS AG | |
02.05.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
01.05.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
01.05.25 | London Stock Exchange (LSE) Buy | UBS AG | |
01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
01.05.25 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
01.05.25 | Glencore Overweight | Barclays Capital | |
01.05.25 | London Stock Exchange (LSE) Buy | Jefferies & Company Inc. | |
01.05.25 | Glencore Buy | Goldman Sachs Group Inc. | |
01.05.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
01.05.25 | GSK Neutral | Goldman Sachs Group Inc. | |
01.05.25 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
01.05.25 | Glencore Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
01.05.25 | HSBC Sector Perform | RBC Capital Markets | |
01.05.25 | HSBC Neutral | JP Morgan Chase & Co. | |
01.05.25 | GSK Neutral | UBS AG | |
30.04.25 | Glencore Buy | Jefferies & Company Inc. | |
30.04.25 | Unilever Kaufen | DZ BANK | |
30.04.25 | GSK Neutral | UBS AG | |
30.04.25 | AstraZeneca Halten | DZ BANK | |
30.04.25 | HSBC Hold | Deutsche Bank AG | |
30.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
30.04.25 | Glencore Outperform | RBC Capital Markets | |
30.04.25 | GSK Hold | Jefferies & Company Inc. | |
30.04.25 | BP Buy | Goldman Sachs Group Inc. | |
30.04.25 | HSBC Buy | Goldman Sachs Group Inc. | |
30.04.25 | BP Overweight | Barclays Capital | |
30.04.25 | GSK Underweight | JP Morgan Chase & Co. | |
30.04.25 | HSBC Neutral | UBS AG | |
29.04.25 | BP Sector Perform | RBC Capital Markets | |
29.04.25 | BP Halten | DZ BANK | |
29.04.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
29.04.25 | AstraZeneca Outperform | Bernstein Research | |
29.04.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
29.04.25 | BP Buy | Jefferies & Company Inc. | |
29.04.25 | BP Sector Perform | RBC Capital Markets | |
29.04.25 | BP Neutral | JP Morgan Chase & Co. | |
29.04.25 | HSBC Neutral | UBS AG |